Single-Electrode Electrochemical System for the Visual and High-Throughput Electrochemiluminescence Immunoassay

The electrochemiluminescence (ECL) immunoassay with its visual and high-throughput detection has received considerable attention in the past decade. However, the development of a facile and cost-effective ECL device is still a great challenge. Herein, a single-electrode electrochemical system (SEES) for the visual and high-throughput ECL immunoassay was developed. The SEES was designed by attaching a plastic sticker with multiple holes onto a single carbon ink screen-printed electrode based on a resistance-induced potential difference. Due to its excellent properties of adsorption and bioaffinity, the carbon ink screen-printed electrode is applied to immobilize antibodies. When cardiac troponin I (cTnI), a specific biomarker of acute myocardial infarction, is present, it will be captured by the immobilized cTnI antibodies on the electrode surface, inhibiting electron transfer, resulting in a decrease of the ECL intensity of the luminol-H2O2 system. Using a smartphone as the detector, cTnI could be determined, ranging from 1 to 1000 ng mL(-1), with a detection limit of 0.94 ng mL(-1). The SEES based on the carbon ink screen-printed electrode is characterized by its high simplicity, cost effectiveness, and user-friendliness compared with conventional three-electrode systems and bipolar electrochemical systems using electrode arrays and shows superior advantages over other immunoassay strategies, with the elimination of multistep assembling and labeling processes. What is more, the fabricated SEES holds great potential in the point-of-care testing due to its tiny size and the combination of a smartphone detector.

Automated summary

A novel single-electrode electrochemical system (SEES) was developed for visual and high-throughput ECL immunoassay. The SEES combines a plastic sticker and carbon ink screen-printed electrode, offering simplicity, cost-effectiveness, and user-friendliness. Using a smartphone as the detector, the SEES enables the determination of the concentration range of a specific biomarker, cTnI, with a low detection limit. Compared to conventional electrode systems, the SEES shows superior advantages and holds great potential in point-of-care testing.